article thumbnail

FDA Approvals: September 2022 Recap

Digital Pharmacist

The FDA protects public health by ensuring the efficacy and safety of human and veterinary drugs, including biological products and medical devices. It is critical for the FDA to continue to develop new advances in therapies to aid our communities in order to achieve better lives through better health. Date of Approval: 9/30/2022.

FDA 75
article thumbnail

FDA approves Wezlana for inflammatory conditions

The Checkup by Singlecare

Food and Drug Administration (FDA) just approved Wezlana (ustekinumab-auub), a biosimilar for the popular drug Stelara. According to the FDA announcement, the most serious side effect of Wezlana is infection because the prescription affects your immune response.

FDA 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Legislation Would Cut Off Access To The Courts And Immunize FDA Actions From Timely Judicial Review

The FDA Law Blog

Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. Subsection 505(q) initially was added by Section 914 of the 2007 FDA Amendments Act (“FDAAA”), Pub.

article thumbnail

FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy

pharmaphorum

AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US. and other XBB subvariants, said the FDA in an update. Evusheld is also ineffective against the BQ.1,

FDA 135
article thumbnail

ACIP Unanimously Recommends Use of Pneumococcal 15-Valent Conjugate Vaccine for Infants and Children

Pharmacy Times

Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.

article thumbnail

FDA approves first drug to prevent Type 1 diabetes

The Checkup by Singlecare

Food and Drug Administration (FDA) approved the first drug to delay the onset of Type 1 diabetes. Tzield received priority review from the FDA, a status given to drugs with the potential for “significant improvement” in the treatment, diagnosis, or prevention of a serious condition. It is expected to be available by the end of 2022.

FDA 98
article thumbnail

The 50 most-filled prescriptions of 2022

The Checkup by Singlecare

Here’s a look at the 50 most-filled prescriptions of 2022. 50 most prescribed drugs of 2022. 1, 2022 through Oct. 31, 2022, excluding opioids and weight-loss drugs. Read on to learn more about the top 10 drugs of 2022. . Prescription drug use in 2022 vs. previous years. Vitamin D (Drisdol, Calciferol).

Dosage 98